Family Medicine

The cannabis-based multiple sclerosis drug Sativex has been recommended for use in Wales, making it the first in the United Kingdom to do so. The drug awaits final approval from the government.

The US Food and Drug Administration recently announced the approval of the KRONUS Zinc Transporter 8 Autoantibody (ZnT8Ab) ELISA Assay, a new test for type 1 diabetes.

The first two Americans to be treated for the Ebola virus on US soil became the first American patients to be discharged from the hospital where they had been kept in isolation for treatment from the virus.

The National Psoriasis Foundation (NPF) recently announced a number of new programs and a five-year strategic mission for the organization with initiatives that are designed to increase research and uncover new treatments for all forms of psoriasis and psoriatic disease.

The United Kingdom's National Institute for Health and Care Excellence (NICE) is recommending Sovaldi as a cost-effective option to treat some people who have chronic hepatitis C.

Between developing its own pipeline of therapies for patients with hepatitis C and acquiring another company known for its work in this field, it looks like Merck is taking steps to be a larger player in HCV market.

As the 2 Americans stricken with Ebola continue to receive treatment in Atlanta, a new potential case of the deadly virus has been reported in California.

New research about food allergies that can trigger severe reactions such as anaphylaxis has shown that cooking some foods can prevent attacks and help build tolerance.

Many control psoriasis-ridden skin only to find traces of discolored patches in its wake. A study by the Milstein Medical Research Program at The Rockefeller University has uncovered the correlation between skin discoloration and psoriasis, providing opportunities of treatment for pigmentation changes within eczema and acne as well.

Every year, more and more Americans are diagnosed with type 2 diabetes mellitus and, according to a recent study, in the near future that number could reach close to 40% of the population.

An emerging epidemic of acute hepatitis C threatens the country's younger population, which experienced a significant hike in the number of cases during a recent 6-year period, according to a compound study that looked at trends of the disease among youth.

A new drug was given tentative approval by the US Food and Drug Administration to help patients with both type 1 and type 2 diabetes.

As the number of people falling victim to the most recent outbreak of the Ebola Virus continues to rise past 1000, aid workers' focus has begun to shift to preventing the spread of Ebola beyond the African continent.

The massive media coverage of the Ebola virus outbreak in West Africa and the coordinated efforts to keep it from spreading has created fertile ground for online scammers peddling so-called Ebola treatments.

Analysis of more than 5,000 successful electrical cardioversions performed without anticoagulation suggests that patients and doctors must act fast to minimize the chances that acute atrial fibrillation will lead to thromboembolic events.

A California-based company has taken the final step toward bringing a cheaper epinephrine injection kit to the American market.

With the help of a grant from the National Institutes of Health, Profectus Biosciences Inc. of Tarrytown, NY, is looking to became one of the key players as medical science looks for a way to prevent future outbreaks of the Ebola Virus.

Belsomra (suvorexant) is the first orexin receptor antagonist approved for insomnia.

Fixed-dose tablet is the first sodium glucose cotransporter 2 (SGLT2) inhibitor plus metformin combo product to receive approval in the US.

Following news that two American Ebola patients were successfully treated with ZMapp, an experimental medication that has not been tested in humans, advocates and aid groups have called for ZMapp and other experimental medications to be made available to the hundreds of patients in West Africa who are still battling the virus.

Adding to the ongoing debate surrounding the health effects of vitamin D, researchers reported vitamin D deficiency was strongly associated with Alzheimer's disease and dementia development.

While doctors and researchers have been busy studying what has caused the most recent outbreak of the Ebola virus and how to stop it, one thing most agree on is that the risk of airborne infection is minimal at best.

Researchers at the University of Washington have manufactured a HIV-combating fabric that can be taken before intercourse and dissolves within minutes.

For schizophrenia patients, there is a connection between deficits in cognition and motivation related to their illness, according to new research.

When administered within 4 to 5 hours of onset of stroke symptoms, alteplase was shown to markedly improve the changes of a good outcome; its benefits diminish the later it is given.

As the African Ebola outbreak continued to spread across West Africa, infecting thousands of people (including at least three Americans so far), the US House of Representatives held a hearing this week to discuss the country's response to the deadly disease.

In just a few short years the number of doctors and hospitals using electronic health records has grown dramatically, according to the US Department of Health and Human Services.

An additional biomarker may predict future epilepsy development in febrile seizure sufferers, according to researchers at the University of California, Irvine.

New research disputes a widely publicized study that linked testosterone replacement therapy with an increased risk of cardiovascular events and all-cause mortality.

Researchers at Auburn University are joining what is becoming a crowded field of teams looking to develop a drug to treat future outbreaks of the Ebola virus.